Recurrence of ovarian squamous cell carcinoma with MET gene copy number variation: a case report and review of literature

被引:0
作者
Xuhui Dong
Lei Yuan
Liangqing Yao
机构
[1] Obstetrics and Gynecology Hospital of Fudan University,Department of Obstetrics and Gynecology
来源
Journal of Ovarian Research | / 13卷
关键词
Ovarian squamous cell carcinoma; Optimal cytoreductive surgery; Recurrence; gene; Copy number variation;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 226 条
  • [1] Goudeli C(2017)An ovarian mature cystic teratoma evolving in squamous cell carcinoma: a case report and review of the literature Gynecol Oncol Rep 19 27-30
  • [2] Varytimiadi A(2012)Squamous cell carcinoma arising in a mature cystic teratoma Case Rep Obstet Gynecol 2012 314535-1180
  • [3] Koufopoulos N(2008)Squamous-cell carcinoma in mature cystic teratoma of the ovary: systematic review and analysis of published data Lancet Oncol 9 1173-868
  • [4] Syrios J(2008)Prognosis and treatment of squamous cell carcinoma from a mature cystic teratoma of the ovary J Formosan Med Assoc 107 857-31
  • [5] Terzakis E(2007)Preoperative diagnosis of mature cystic teratoma with malignant transformation: analysis of imaging findings and clinical and laboratory data Arch Gynecol Obstet 275 25-1022
  • [6] Avci S(1997)Squamous cell carcinoma arising from mature cystic teratoma of the ovary: a clinicopathologic analysis Obstet Gynecol 89 1017-748
  • [7] Selcukbiricik F(2017)Elevated preoperative neutrophil : lymphocyte ratio as a preoperative indicator of mature cystic teratoma with malignant transformation J Obstet Gynaecol Res 43 744-614
  • [8] Bilici A(2016)A review of squamous cell carcinoma arising in mature cystic teratoma of the ovary Indian J Cancer 53 612-2517
  • [9] Ozkan G(2019)Clinical outcome of patients with malignant tumors associated with mature cystic Teratomas of the ovary: a retrospective multicenter Italian study Anticancer Res 39 2513-771
  • [10] Ozagari AA(2010)Malignant transformation arising from mature cystic Teratoma of the ovary Int J Gynecol Cancer 20 766-144